Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 128

1.

Epstein-Barr virus-encoded miR-BART20-5p inhibits T-bet translation with secondary suppression of p53 in invasive nasal NK/T-cell lymphoma.

Lin TC, Liu TY, Hsu SM, Lin CW.

Am J Pathol. 2013 May;182(5):1865-75. doi: 10.1016/j.ajpath.2013.01.025.

PMID:
23608226
2.

EBV-encoded miR-BART20-5p and miR-BART8 inhibit the IFN-γ-STAT1 pathway associated with disease progression in nasal NK-cell lymphoma.

Huang WT, Lin CW.

Am J Pathol. 2014 Apr;184(4):1185-97. doi: 10.1016/j.ajpath.2013.12.024.

PMID:
24655378
3.

The PTEN-AKT-mTOR/RICTOR Pathway in Nasal Natural Killer Cell Lymphoma Is Activated by miR-494-3p via PTEN But Inhibited by miR-142-3p via RICTOR.

Chen HH, Huang WT, Yang LW, Lin CW.

Am J Pathol. 2015 May;185(5):1487-99. doi: 10.1016/j.ajpath.2015.01.025.

PMID:
25907832
4.

MicroRNA profiling of Epstein-Barr virus-associated NK/T-cell lymphomas by deep sequencing.

Motsch N, Alles J, Imig J, Zhu J, Barth S, Reineke T, Tinguely M, Cogliatti S, Dueck A, Meister G, Renner C, Grässer FA.

PLoS One. 2012;7(8):e42193. doi: 10.1371/journal.pone.0042193. Epub 2012 Aug 3.

5.

MicroRNA miR-BART20-5p stabilizes Epstein-Barr virus latency by directly targeting BZLF1 and BRLF1.

Jung YJ, Choi H, Kim H, Lee SK.

J Virol. 2014 Aug;88(16):9027-37. doi: 10.1128/JVI.00721-14. Epub 2014 Jun 4.

6.

Epstein-Barr virus miR-BART20-5p regulates cell proliferation and apoptosis by targeting BAD.

Kim H, Choi H, Lee SK.

Cancer Lett. 2015 Jan 28;356(2 Pt B):733-42. doi: 10.1016/j.canlet.2014.10.023. Epub 2014 Oct 24.

PMID:
25449437
7.

Downregulation of miR-15a due to LMP1 promotes cell proliferation and predicts poor prognosis in nasal NK/T-cell lymphoma.

Komabayashi Y, Kishibe K, Nagato T, Ueda S, Takahara M, Harabuchi Y.

Am J Hematol. 2014 Jan;89(1):25-33. doi: 10.1002/ajh.23570. Epub 2013 Sep 30.

8.

Regulation of the MIR155 host gene in physiological and pathological processes.

Elton TS, Selemon H, Elton SM, Parinandi NL.

Gene. 2013 Dec 10;532(1):1-12. doi: 10.1016/j.gene.2012.12.009. Epub 2012 Dec 14. Review.

PMID:
23246696
9.

Circulating Epstein-Barr virus-encoded micro-RNAs as potential biomarkers for nasal natural killer/T-cell lymphoma.

Komabayashi Y, Kishibe K, Nagato T, Ueda S, Takahara M, Harabuchi Y.

Hematol Oncol. 2017 Dec;35(4):655-663. doi: 10.1002/hon.2360. Epub 2016 Oct 6.

PMID:
27709652
10.

Profiling of Virus-Encoded MicroRNAs in Epstein-Barr Virus-Associated Gastric Carcinoma and Their Roles in Gastric Carcinogenesis.

Shinozaki-Ushiku A, Kunita A, Isogai M, Hibiya T, Ushiku T, Takada K, Fukayama M.

J Virol. 2015 May;89(10):5581-91. doi: 10.1128/JVI.03639-14. Epub 2015 Mar 4.

11.

Epstein-Barr Virus MicroRNA miR-BART20-5p Suppresses Lytic Induction by Inhibiting BAD-Mediated caspase-3-Dependent Apoptosis.

Kim H, Choi H, Lee SK.

J Virol. 2015 Nov 18;90(3):1359-68. doi: 10.1128/JVI.02794-15. Print 2016 Feb 1.

12.

Epstein-Barr virus-associated natural killer/T-cell lymphomas.

Asano N, Kato S, Nakamura S.

Best Pract Res Clin Haematol. 2013 Mar;26(1):15-21. doi: 10.1016/j.beha.2013.04.002. Epub 2013 May 25. Review.

PMID:
23768637
13.

Transcription factors engaged in development of NK cells are commonly expressed in nasal NK/T-cell lymphomas.

Zhang S, Li T, Zhang B, Nong L, Aozasa K.

Hum Pathol. 2011 Sep;42(9):1319-28. doi: 10.1016/j.humpath.2009.11.022. Epub 2011 Feb 16.

PMID:
21329961
14.

[Expression of microRNA in extranodal NK/T cell lymphoma, nasal type].

Ti HJ, Nong L, Wang W, Zhang S, Li T.

Zhonghua Bing Li Xue Za Zhi. 2011 Sep;40(9):610-5. Chinese.

PMID:
22177245
15.
16.

Expression of Epstein-Barr virus-encoded proteins in extranodal NK/T-cell Lymphoma, nasal type (ENKL): differences in biologic and clinical behaviors of LMP1-positive and -negative ENKL.

Kanemitsu N, Isobe Y, Masuda A, Momose S, Higashi M, Tamaru J, Sugimoto K, Komatsu N.

Clin Cancer Res. 2012 Apr 15;18(8):2164-72. doi: 10.1158/1078-0432.CCR-11-2395. Epub 2012 Feb 27.

17.

Dysregulated microRNAs affect pathways and targets of biologic relevance in nasal-type natural killer/T-cell lymphoma.

Ng SB, Yan J, Huang G, Selvarajan V, Tay JL, Lin B, Bi C, Tan J, Kwong YL, Shimizu N, Aozasa K, Chng WJ.

Blood. 2011 Nov 3;118(18):4919-29. doi: 10.1182/blood-2011-07-364224. Epub 2011 Sep 14. Erratum in: Blood. 2014 Jan 9;123(2):302.

18.

High level of viral microRNA-BART20-5p expression is associated with worse survival of patients with Epstein-Barr virus-associated gastric cancer.

Kang BW, Choi Y, Kwon OK, Lee SS, Chung HY, Yu W, Bae HI, Seo AN, Kang H, Lee SK, Jeon SW, Hur K, Kim JG.

Oncotarget. 2017 Feb 28;8(9):14988-14994. doi: 10.18632/oncotarget.14744.

19.

Clinicopathologic and molecular features of 122 Brazilian cases of nodal and extranodal NK/T-cell lymphoma, nasal type, with EBV subtyping analysis.

Gualco G, Domeny-Duarte P, Chioato L, Barber G, Natkunam Y, Bacchi CE.

Am J Surg Pathol. 2011 Aug;35(8):1195-203. doi: 10.1097/PAS.0b013e31821ec4b5.

PMID:
21716086
20.

Establishment and Characterization of a CD20-Positive NK/T-Cell Lymphoma Cell Line.

Gu L, Hong L, Ling Z, Feng J, Zheng Z, Du L, Mou H, Sun W, Kong X, Ling Y, Jiang Z, Zhu C, Mao W, Qian L.

Clin Lab. 2015;61(7):731-9.

PMID:
26299072

Supplemental Content

Support Center